The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1.

Patients with low FOXO1 transcript expression showed a higher risk of biochemical relapse than patients with high FOXO1 transcript expression ( Figure S7A ) and ROC analysis showed a borderline significance for discrimination of recurrent and non-recurrent patients by FOXO1 expression (AUC: 0.69, P = 0.05, Figure S5B ).

also in 7,017 other papers